MediWound expects about $15 million for working capital and general needs, giving it more cash. But issuing 1,200,000 shares, with up to 180,000 more possible, leaves current owners with a smaller share, making the sale unfavorable.
The cash gives MediWound funds for working capital and general company needs. But it comes from selling shares, and the underwriter may buy even more. Current owners would hold a smaller piece of the company, so the share sale weighs negatively.
Follow MediWound Ltd. (MDWD) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MDWD